322 related articles for article (PubMed ID: 25834613)
1. Effectiveness of Breast MRI and (18)F-FDG PET/CT for the Preoperative Staging of Invasive Lobular Carcinoma versus Ductal Carcinoma.
Jung NY; Kim SH; Kim SH; Seo YY; Oh JK; Choi HS; You WJ
J Breast Cancer; 2015 Mar; 18(1):63-72. PubMed ID: 25834613
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
[TBL] [Abstract][Full Text] [Related]
3. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of 18F-FDG-PET in Invasive Lobular Carcinoma.
Fujii T; Yajima R; Kurozumi S; Higuchi T; Obayashi S; Tokiniwa H; Nagaoka R; Takata D; Horiguchi J; Kuwano H
Anticancer Res; 2016 Oct; 36(10):5481-5485. PubMed ID: 27798919
[TBL] [Abstract][Full Text] [Related]
5. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
Jung NY; Kim SH; Choi BB; Kim SH; Sung MS
World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560
[TBL] [Abstract][Full Text] [Related]
6. [Preoperative MRT of the breast in invasive lobular carcinoma in comparison with invasive ductal carcinoma].
Diekmann F; Diekmann S; Beljavskaja M; Bick U; Taupitz M; Blohmer JU; Winzer KJ; Hamm B
Rofo; 2004 Apr; 176(4):544-9. PubMed ID: 15088179
[TBL] [Abstract][Full Text] [Related]
7. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of 18F-FDG PET/CT in low 18F-FDG-avidity breast cancer subtypes: comparison with breast US and MRI.
Park HL; Yoo IR; O JH; Kim H; Kim SH; Kang BJ
Nucl Med Commun; 2018 Jan; 39(1):35-43. PubMed ID: 28984814
[TBL] [Abstract][Full Text] [Related]
9. Prospective Pilot Study of
Covington MF; Hoffman JM; Morton KA; Buckway B; Boucher KM; Rosenthal RE; Porretta JM; Brownson KE; Matsen CB; Vaklavas C; Ward JH; Wei M; Buys SS; Chittoria N; Yakish ED; Archibald ZG; Burrell LD; Butterfield RI; Yap JT
AJR Am J Roentgenol; 2023 Aug; 221(2):228-239. PubMed ID: 36919879
[No Abstract] [Full Text] [Related]
10. Head-to-Head Evaluation of
Ulaner GA; Jhaveri K; Chandarlapaty S; Hatzoglou V; Riedl CC; Lewis JS; Mauguen A
J Nucl Med; 2021 Mar; 62(3):326-331. PubMed ID: 32680923
[TBL] [Abstract][Full Text] [Related]
11. Dual-Time
Ozen A; Altinay S; Ekmekcioglu O; Albayrak R; Muhammedoglu A; Yigitbas H; Bastug E; Celik A
Indian J Surg; 2016 Oct; 78(5):382-389. PubMed ID: 27994334
[TBL] [Abstract][Full Text] [Related]
12. Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.
Dashevsky BZ; Goldman DA; Parsons M; Gönen M; Corben AD; Jochelson MS; Hudis CA; Morrow M; Ulaner GA
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1666-1673. PubMed ID: 25971426
[TBL] [Abstract][Full Text] [Related]
13. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?
Sarikaya I; Sarikaya A; Albatineh AN; Tastekin E; Sezer YA
Asia Ocean J Nucl Med Biol; 2020; 8(1):27-35. PubMed ID: 32064280
[TBL] [Abstract][Full Text] [Related]
16. Axillary Lymph Node-to-Primary Tumor Standard Uptake Value Ratio on Preoperative (18)F-FDG PET/CT: A Prognostic Factor for Invasive Ductal Breast Cancer.
Kim YH; Yoon HJ; Kim Y; Kim BS
J Breast Cancer; 2015 Jun; 18(2):173-80. PubMed ID: 26155294
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.
Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N
Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703
[TBL] [Abstract][Full Text] [Related]
18. A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Bhaludin BN; Tunariu N; Koh DM; Messiou C; Okines AF; McGrath SE; Ring AE; Parton MM; Sharma B; Gagliardi T; Allen SD; Pope R; Johnston SRD; Downey K
Eur Radiol; 2022 Sep; 32(9):6514-6525. PubMed ID: 35384456
[TBL] [Abstract][Full Text] [Related]
19. Population-based study of the sensitivity of axillary ultrasound imaging in the preoperative staging of node-positive invasive lobular carcinoma of the breast.
Morrow E; Lannigan A; Doughty J; Litherland J; Mansell J; Stallard S; Mallon E; Romics L
Br J Surg; 2018 Jul; 105(8):987-995. PubMed ID: 29623677
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous whole-body ¹⁸F-FDG PET-MRI in primary staging of breast cancer: a pilot study.
Taneja S; Jena A; Goel R; Sarin R; Kaul S
Eur J Radiol; 2014 Dec; 83(12):2231-2239. PubMed ID: 25282709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]